XML 33 R5.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
6 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Cash flows from operating activities:    
Net loss $ (20,237,649) $ (7,045,645)
Adjustments to reconcile net loss to net cash used in operating activities:    
Common stock, stock options and warrants issued as payment for compensation, services rendered and interest expense 6,656,953 4,339,693
Depreciation and amortization 4,582,873 1,465,220
Loss on short term investments   34,717
Amortization of preferred stock discount and issuance cost 1,329,187  
Changes in fair value of derivative liability (295,356)  
Write off of acquired in process research and development 927,000  
Loss on disposal of assets 396,635  
Charitable contributions paid with common stock 607,363  
Bad debt expense (29,442) 28,176
Deferred income taxes (351,320) (121,244)
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets (26,887) (78,895)
Accounts receivable (882,410) (286,184)
Inventory (1,495,358) (3,331,720)
Unearned revenues 134,202 (647,749)
Other assets 97,248 (78,900)
Accounts payable, accrued expenses and other current liabilities (4,678,560) 2,258,073
Net cash used in operating activities (13,265,520) (3,464,458)
Cash flows from investing activities:    
Cash received in acquisition of PCT 227,942  
Purchase of short term investments (24) (2,430,388)
Proceeds from short term investments   2,390,602
Change in restricted cash used as collateral for notes payable (1,407,483) 639,944
Acquisition of property and equipment (5,237,141) (8,634,298)
Net cash used in investing activities (6,416,706) (8,034,140)
Cash flows from financing activities:    
Net proceeds from the exercise of warrants   2,493,750
Net proceeds from the exercise of options 7,100 140,100
Net proceeds from issuance of capital stock 5,907,723 13,565,504
Payment from related party 644,414 375,135
Repayment of mortgage loan (64,366)  
Proceeds of bank loan 4,592,000  
Proceeds from notes payable 10,950,616 11,046,833
Repayment of notes payable (9,781,781) (9,988,213)
Repayment of debt to related party (3,406,043)  
Repayment of bank loan   (2,209,500)
Payment of dividend   (222,922)
Net cash provided by financing activities 8,849,663 15,200,687
Impact of changes of foreign exchange rates 70,582 97,318
Net (decrease)/increase in cash and cash equivalents (10,761,981) 3,799,407
Cash and cash equivalents at beginning of year 15,612,391 7,159,369
Cash and cash equivalents at end of period 4,850,411 10,958,776
Cash paid during the period for:    
Interest 1,333,800 207,500
Taxes 1,634,500 999,800
Supplemental Schedule of non-cash investing activities    
Acquisition of property and equipment 1,283,400 418,000
Capitalized interest 212,000 205,300
Supplemental schedule of non-cash financing activities    
Common stock and warrants issued with the acquisition of PCT 17,866,200  
Common stock issued pursuant to the redemption of Convertible Redeemable Series E 7% Preferred Stock 1,959,600  
Common stock issued in payment of dividends for the Convertible Redeemable Series E 7% Preferred Stock 475,200  
Financing costs for capital stock raises   463,400
Conversion of Convertible Redeemable Series C Preferred Stock   13,720,000
Dividend to Related Party reinvested as loan payable $ 11,726,000